Saratov JOURNAL of Medical and Scientific Research

Modern aspects of diagnosis of bone metabolism in children with juvenile idiopathic arthritis

Year: 2014, volume 10 Issue: №3 Pages: 422-427
Heading: Pediatrics Article type: Review
Authors: Spivakovskaya A.Y., Chernenkov Y.V., Spivakovsky У.М.
Organization: Saratov State Medical University

The review deals with the diagnosis of changes in bone metabolism in children with juvenile idiopathic arthritis (JIA) in terms of disclosure of the pathogenetic mechanisms of immunopathological disorders in the body. It is shown that timely and adequate characterization of the state of mineralization of bone tissue in patients with JIA — as an indicator of systemic catabolic process, remains an ongoing problem, entailing the need for large-scale introduction of new diagnostic techniques. Through the presentation of the traditional methods of diagnosis of bone metabolism, their capabilities, strengths and weaknesses, analyze the advantages of assessing the level of bone formation, taking into account a variety of biochemical markers. The data on the development of modern diagnostic approaches to the assessment of osteopenia complications in children with JIA, based on the characterization of molecular-genetic targets of the process of osteogenesis. Conclusion: for the adequate therapy and its timely correction in children with JIA in the early stages of the disease it is necessary to carry out a comprehensive study on the identification of metabolic disorders of bone, holding it in the dynamics, and actively introducing the practice of modern and affordable methods of diagnosis of osteopenic disorders.

1. Vorobjev PA, Alekseeva El, Bezmelnicina LY, et al. The study of epidemiology, drug therapy and functional status of patients with juvenile rheumatoid arthritis in Russia. Clinical pharmacology and pharmacoeconomics 2011; (4): 74-75
2. Kaladze NN, Sarchuk EV. Peculiarities in the structural-functional state of the bone-muscular system in patients with juvenile rheumatoid arthritis. Health 2012; 4(39): 52-56
3. Nasonov EL. Rheumatology in Russia in the beginning of XXI century. Therapeutic archive 2013; 85 (5): 4-7
4. Alekseeva El, Baranov АА, Bzarova ТМ, et al. Juvenile arthritis: clinical guidelines for pediatricians. Children rheumatology. Moscow: Pediatrb, 2013; 120 p.
5. Bezmelnicina LY. Scientific substantiation of improvement of organization of medical aid to children with rheumatic diseases: PhD abstract. Moscow, 2014; 24 p.
6. Nasonov EL, Baranov АА, Erdes ShF, et al. State specialized rheumatic assistance to children and adults in the Russian Federation: The project of the Federal Target Program "Rheumatic diseases 2008-2012. Scientific-practical rheumatology 2007; (2): 4-7
7. Folomeeva ОМ, Galushko ЕА, Erdes SF. Prevalence of rheumatic diseases in the adult population of Russia and the USA. Rheumatology Science & Practice 2008; (4): 4-13
8. Strukov VI, Sergeeva-Kondrachenko MU, Strukova-Jouns OV, et al. Actual problems of osteoporosis. Ed. VI Strukov. Printing Rostra, 2009; 342 p.
9. Kaladze NN. Osteoporosis and URA. Taurida medikobiologykal vestnik 2004; (3): 6872-6876
10. OstrovskiyAB, Otteva EN, Tarnavskaja TS. Osteoporosis rheumatoid arthritis. Far-Eastern medical journal 2012; (4): 142-144
11. Pavlyshyn GA, KovalchukTA, Garijan TV. Functional state of musculoskeletal system in patients with juvenile rheumatoid arthritis children on the results of polling Ukrainian adapted version of the questionnaire CHAQ. Pediatrics. Eastern Europe 2013; (2): 13-23
12. Nasonov EL, Gukasjan DA, Nasonova MB. Immunopathology of rheumatoid arthritis and osteoporosis: new data. Osteoporosis and osteopathy 2000; (2): 4-7
13. Smirnov AV, Karateev DE. Stage radiographic changes in the joints in rheumatoid arthritis. Rus Med Jour 2014; (7): 551-554
14. Gerbel MN. Osteopaticheskii manifestations of juvenile rheumatoid arthritis in children based on clinical variants and therapy: PhD abstract. Samara, 2006; 20 p.
15. Marcus R, Feldman D, Nelson DA, Rosen CJ, editors. Fundamentals of Osteoporosis. Amsterdam/Boston/ Heidelberg/ London: Academic Press; 2010; 537 p.
16. Lebedev KA, Ponjakina ID. Immunology obrazraspoznayushchikh receptors (integrated immunology). Moscow: Book house «Librokom», 2009; 256 p.
17. DionyssiotisY, editor. Osteoporosis. Croatia, 2012; 864 р.
18. Belyaeva LM. Joint Disease in children and adolescents. Minsk: BelMAPO, 2006; 60 p.
19. Kostik MM. Clinical and genetic factors affecting bone health in children with rheumatic diseases: PhD abstract. St. Petersburg, 2005; 24 p.
20. Osteoporosis: Diagnostics, prophylaxis and treatment: a clinical recommendations / Under, editor O. Lesnyak, L. Benevolensky. 2nd ed. M: GEOTAR-Media 2010; 272 p.
21. Clinical biochemistry: classic University textbook/ed. VA. Tkachuk 2nd ed., corr. and supplementary). Moscow: GEOTAR-MED, 2004; 512 p.
22. Alehnovich LI. Characteristics of biochemical markers of bone metabolism. Recept (special issue) 2009: 17-25
23. Mesko D. Differential diagnosis by laboratory medicine. Ed. Springer, 2002; p. 319-321
24. Garnero P, Vergnaud P, Hoyle N. Evaluation of a fully automated serum assay for total N-terminal propeptide of type I collagen in postmenopausal osteoporosis. Clin Chem 2008; 54 (1): 188-196
25. Pagani F, Francucci CM, Moro L. Markers of bone turnover: biochemical and clinical perspectives. J Endocrinol Invest 2005; 28 (10): 8-13
26. Churilina AV, Moskaluk ON. Metabolic disorders of connective tissue in certain pathological conditions in children. Journal of child Health 2006; 1 (1): 47-49
27. LilaAM, BuderusYS. Some indicatorsof bone metabolism in patients with rheumatoid arthritis. Vesnik North-Western state medical University n.a. 1.1. Mechnikov 2013; (4): 35-39
28. McClung Michael Role of RANKL inhibition in osteoporosis. Arthritis Research & Therapy 2007; 9 (1): 3-13
29. Ainola M, Mandelin J, Liljestrbm M, et al. Imbalanced expression of RANKL and osteoprotegerin mRNA in pannus tissue of rheumatoid arthritis. Clin Exp Rheumatol 2008; 26 (2): 240-6
30. Wen-Feng Li, Shu-Xun Hou, Bin Yu, et al. Genetics of osteoporosis: perspectives for personalized medicine. Personalized Medicine 2010; 7 (6): 655-668
31. Xu S, Wang Y, Lu J, Xu J. Osteoprotegerin and RANKL in the pathogenesis of rheumatoid arthritis-induced osteoporosis. Rheumatol Int. 2012; 82: 3397-403
32. Yi Dai Correlation of Circulating Matrix Metalloproteinase-3 and Osteopontin Levels with Postmenopausal Osteoporosis. J Trauma Treat 2013; 2(3): 171-175
33. Kuznecova LV, Zazerskaja IE, Sudakov DS. The role of evaluation of biochemical markers of bone metabolism in the control treatment of postmenopausal osteoporosis. Clinical and laboratory consulting board 2008; 6 (25): 39-45
34. Ainola М, Li TF, Mandelin J, et al. Involvement of a disintegrin and a metalloproteinase 8 (ADAM8) in osteoclastogenesis and pathological bone destruction. Ann Rheum Dis 2009; 68 (3): 427-434
35. Demidenko YL. The state of bone metabolism and its correction in and disseminated locally advanced prostate cancer: DSc abstract. Moscow, 2010; 40 p.
36. Iljina RY, Muhamedjanova LR, Urakova EV. The changes of biochemical markers of bone metabolism in the background of drug osteoporosis in psychiatric patients. Practical medicine 2013; 1-2 (2): Actual problems of medicine. Psychiatry. Rheumatology. (access on 20 June 2014)
37. Didikina IS, Vetkova ES. Sclerostin and its role in the regulation of bone tissue metabolism. Research-to-practice rheumatology 2013; 3 (51): 296-301
38. Harris SS, Pettel MS, Cole DEC. Association of collagen type 1a 1 Sp1 polymorphism with five-year rates of bone loss in older adults. Calcif Tissue Int 2000; (66): 268-271
39. Kostik MM, Smirnov AM, Demin GS, et al. Genetic polymorphisms of collagen type 1 a1 chain (COL1A1) gene increase the freguency of low bone mineral density in the subgroup of children with juvenile idiopathic arthritis. EPMA J 2013; 4: 15
40. Vasileva TG, Kochetkova EA, Antonenko FF. Association gene collagen and vitamin D receptor with osteopenic syndrome in juvenile arthritis in children. Pediatrics 2008; 5 (87): 41-44
41. Tyrtova DA, Erman MV, Tyrtova LV, et al. Osteoporosis in childhood and adolescence: the state of the problem: Message 1. Vestnik of Saint Petersburg University 2009; 2(11): 164-177
42. Del Fattore A, Peruzzi В, Rucci N, et al. Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment. J Med Genet 2006; 43: 315-325
43. Del Fattore A, Cappariello A, Teti A. Genetics, pathogenesis and complications of osteopetrosis. Bone 2008; 42: 19-29
44. Дворниченко MB, Саприна ТВ, Некрасова AM, Нечаев KA, Кондратьева ЕЙ, Митриченко ДВ. Обзор молекулярно-генетических аспектов регуляции процессов ремоделирова-ния костной ткани у детей. Sintel 2010 [доступ 10 июня 2014]. URL: html
45.SiposW, Pietschmann Р, RaunerM,etal. Pathophysiology of osteoporosis. Wien Med Wochenschr. 2009; 159 (9-10): 230-234
46. Maruotti N, Corrado A, Cantatore FP Osteoporosis and rheumatic diseases. Reumatismo 2014; 66 (1): 125-135
47. Geusens PP, Lems WF. Osteoimmunology and osteoporosis. Arthritis Res Ther 2011; 13: 242
48. Walsh NC, Gravallese EM. Bone remodeling in rheumatic diseasae: a guestion of balance. Immunol Rev 2010; 233: 301-12
49. Maruotti N, d'Onofrio F, Corrado A, Cantatore FP. TNF-a inhibition is not sufficient to avoid juxta-articular erosions in chronic arthritis? Intern Emerg Med 2012; 7: 15-20
50. Yerges LM, Klei L, Cauley JA, et al. High-density association study of 383 candidate genes for volumetric BMD at the femoral neck and lumbar spine among older men. Lakartidningen 2006; 103 (40): 2972-5

2014_03_422-427.pdf417.08 KB

No votes yet